Eton Pharmaceuticals (ETON) Shares Outstanding (Weighted Average) (2019 - 2025)
Historic Shares Outstanding (Weighted Average) for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $26.9 million.
- Eton Pharmaceuticals' Shares Outstanding (Weighted Average) rose 383.4% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year increase of 383.4%. This contributed to the annual value of $25.9 million for FY2024, which is 97.37% up from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Shares Outstanding (Weighted Average) is $26.9 million, which was up 383.4% from $26.9 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $26.9 million in Q2 2025 and a low of $25211.0 during Q2 2021
- Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $25.3 million (2022), whereas its average is $20.3 million.
- Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first crashed by 9989.91% in 2023, then skyrocketed by 10083373.95% in 2024.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $25.2 million in 2021, then decreased by 0.24% to $25.1 million in 2022, then rose by 1.99% to $25.6 million in 2023, then rose by 0.97% to $25.9 million in 2024, then increased by 3.85% to $26.9 million in 2025.
- Its Shares Outstanding (Weighted Average) was $26.9 million in Q3 2025, compared to $26.9 million in Q2 2025 and $26.9 million in Q1 2025.